(redirected from Beta-glucans)
Also found in: Medical.


 (bā′tə-glo͞o′kăn′ -kən)
Any of various polysaccharides, such as cellulose, that are composed of glucose monomers and are found chiefly in the cell walls of fungi and plants, especially oats and barley. Beta-glucans are added to foods as a source of dietary fiber and are used as dietary supplements.
References in periodicals archive ?
37,38) Beta-glucans are glucose polymers derived from yeast, fungi, or from oats.
While you may have heard more about beta-glucans from mushrooms, yeast-derived beta-glucans are the most extensively studied form.
So, for both hull-less and hulled varieties, beta-glucanase enzymes are used in fermentation to dramatically break down high-viscosity beta-glucans into low-viscosity oligosaccharides, solving the beta-glucan problem, according to Dennis O'Brien, an ERRC chemical engineer.
Among their topics are the epidemiological evidence, glucan-induced pulmonary inflammation in rats, organ distribution and degradation mechanisms of fungal beta-glucans in the body, and detecting and measuring the glucans with limulus amebocyte lysate-based reagents.
Aventure says the patented brewing process uses oats rather than barley and employs a special enzyme technology results in a product rich in beta-glucans, fibres shown in research to have a beneficial effect on cholesterol levels.
24) Apparently, the beta-glucans present in Fraction D, unlike those found in Fraction SX, cannot influence SBP, at least at the doses examined here.
The substance, a white powder called Nu-Trim, contains high concentrations of beta-glucans, soluble fibers that have been shown to lower cholesterol (SN: 5/26/90, p.
And beta-glucans from oats have been reported to lower blood cholesterol and triglycerides.
Investigators then began looking for the most effective immune-boosting constituents in the mushroom, finding that a unique beta-glucan from the Maitake proved to be most efficacious, particularly when taken orally--of particular import since the concern with beta-glucans has been oral bioavailability.
Svein Lien, Biotec CEO, said that the new US patent adds to several other patents and pending patent applications in a number of countries, further strengthening the company's positions in cancer antibody treatment using beta-glucans.